Reich, K.; Lebwohl, M.; Paul, C.; Ropke, M.; Rosen, M.; Hansen, K. Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients With Moderate-to-Severe Psoriasis. J of Skin 2018, 2, S1.